Back to search
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis trials you may qualify forThis Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
A Study to Evaluate the Efficacy, Safety and Tolerability of AZD2693 given by subcutaneous injection in adult participants with non-cirrhotic non-alcoholic stea…
The purpose of this study is to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic NASH with fibrosis.